A virtual advocacy platform to foster collaboration and improve patient outcomes

The Advocacy Exchange is a virtual platform created by GRYT Health and Bristol Myers Squibb (BMS), to unite advocacy organisations, patients and industry leaders in improving outcomes for people living with cancer.

GRYT Health is a digital oncology company that was started and is run by cancer patients, survivors, caregivers and researchers. Its goal is to provide support and resources to improve the experiences of people living with cancer and strengthen the patient voice in healthcare decision-making.

The company partnered with the global biopharmaceutical company and UICC partner BMS to create The Advocacy Exchange, a virtual platform that aims to unite advocacy organisations, patients and industry leaders in the exchange of information on cancer experiences. It is a global collaboration to foster meaningful growth and partnership across disease areas to improve outcomes for patients.

Created initially to support the urgent needs of the patient advocacy community as the COVID Advocacy Exchange (CAE), The Advocacy Exchange offers live, interactive discussions through which patient voices can be heard, and a virtual exhibit hall where participating organisations, such as UICC, can share resources and learn from one another.

Register today at TheAdvocacyExchange.com

Tags The Advocacy Exchange GYRT Health Bristol-Myers Squibb

Last update

Monday 02 August 2021

Related content

While the 5th edition of Country 2 Country 4 Cancer, due to take place this September, had to be called off because of COVID-19, Bristol-Myers Squibb, who sponsors the event, is continuing its generous support of UICC member organisations.

2019 C2C4C riders arrive at Bristol-Myers Squibb office in London, UK on 27 Sept. 2019

The fourth edition of the European Country 2 Country 4 Cancer (C2C4C) ride - which started on 9 September in Munich – came to an end with riders crossing the finish line at the Bristol-Myers Squibb (BMS) London office in Uxbridge.